ExCellThera

David Millette, CEO and Chief Operating Officer 

Oct. 11 | 11:00am | Oxford Biomedica Ballroom 

Montreal, Canada 

(Private) 

In-person Presentation 

ExCellThera is a clinical-stage cell expansion and engineering company delivering molecules and bioengineering solutions to expand and engineer various cell lines for use in novel one-time curative therapies for patients with hematologic malignancies and other diseases. ExCellThera’s most advanced technology, ECT-001 Cell Therapy, combines a proprietary molecule, UM171, and an optimized culture system. In pursuit of better treatments for patients, the company is building out its cell expansion and engineering platform, as well as supporting best-in-class clinical trials. 

www.excellthera.com 



By using this website you agree to accept our Privacy Policy and Terms & Conditions